1. Hematopoiesis and Immune Environment

Program No	Name	Title
1-G-W13-9-O/P	Tatsuya Shishido (Osaka University)	Crucial role of CD74 in hematopoietic cell differentiation
1-G-W13-10-O/P	Masashi Kanayama (Duke University School of Medicine)	Balancing population sizes of myeloid and lymphoid cells by osteopontin isoforms

2. B cells

Program No	Name	Title
3-E-W34-2-O/P	Hisashi Nomura (Keio University School of Medicine)	FcγRIIb plays an important role in maintaining clonal ignorance and prevents pemphigus phenotype in pathogenic anti-desmoglein 3 antibody knock-in mice
3-E-W35-3-O/P	Kei Haniuda (Tokyo University of Science)	Germinal center B cell development by glycolysis and mitochondrial metabolism

3. T cells

Program No	Name	Title
3-I-W42-4-O/P	Ryunosuke Muro (The University of Tokyo)	Control of proinflammatory γδT cell development by linage-specific TCR signaling pathway
3-I-W43-15-O/P	Michio Miyajima (RIKEN Yokohama Institute)	Systemic metabolic shift induced by PD-1 deficiency perturbs brain monoamines and emotional behaviour

4. Helper T cells

Program No	Name	Title
1-I-W18-8-O/P	Makoto Kuwahara (Ehime University)	The transcriptional repressor Bach2 regulates differentiation of pathogenic Th2 cells
1-I-W18-10-O/P	Masaki Tajima (NIAID, NIH)	IL-10-Producing Tr2 cells Induced by mTOR/CEBPβ Signaling Regulate Hyphal C. albicans Kidney Infection

5. Innate lymphocytes

Program No	Name	Title
3-B-W28-11-O/P	Goh Murayama (Juntendo University School of Medicine)	Role of mucosal-associated invariant T cells in lupus pathogenesis
3-B-W29-9-O/P	Mariko Kamioka (The University of Tokyo)	Innate and adaptive immune cells regulate Paneth cell granule formation and α-defensin secretion

6. Dendritic cells and macrophages

Program No	Name	Title
3-C-W30-11-O/P	Miyuki Watanabe (Osaka University)	Early FcRγ-Erk signaling determines cytokine profile of dendritic cells through C-type lectin receptors
3-C-W31-7-O/P	Akihiro Kimura (Research Institute National Center for Global Health and Medicine)	The novel ubiquitin ligase complex, NQO1-PDLIM2 inhibits TLR-dependent production of selective cytokines by degrading IκB-ζ

7. Mast cells & granulocytes

Program No	Name	Title
3-H-W40-21-O/P	Jun-ichi Kashiwakura (Hokkaido University)	STAP-2 is an adopter molecule to positively regulate basophil activation
3-H-W40-27-O/P	Kensuke Miyake (Tokyo Medical and Dental University (TMDU))	Basophils exert antigen presentation via trogocytosis-mediated acquisition of peptide-MHC class II complexes from dendritic cells (DCs)

8. Allergy

Program No	Name	Title
1-A-W1-4-O/P	Koji Hayashizaki (Chiba University)	Myosin light chains 9 and 12 are functional ligands for CD69 that regulate airway inflammation
2-G-W23-1-O/P	Kazuhiko Yamamura (Kyushu University)	The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction

9. Cytokines and chemokines

Program No	Name	Title
1-H-W15-9-O/P	Hironao Suzuki (Hokkaido University)	RNA Splicing Mediator 1 (RSM1) regulates inflammation via alternative splicing of DNA methyltransferase Dnmt3b
1-H-W16-4-O/P	Yurina Miyajima (RIKEN IMS)	Function of BMP2 and BMP7 produced by ILC2 in the adipose tissue

10. Tolerance and Immune suppression

Program No	Name	Title
3-A-W26-2-O/P	Hikari Okamura (Tokushima University)	Single-cell analysis of autoreactive T cells under the control of PD-1
3-A-W26-10-O/P	Kazuki Kishida (Osaka University)	Antigen-specific immune regulation mediated by TCR-like antibodies

11. Virus infection

Program No	Name	Title
1-D-W7-8-O/P	Haruna Okude (Nara Institute of Science and Technology)	Induction of cell death by imiquimod (R837) and its role in immune responses
1-D-W8-7-O/P	Daichi Yamasoba (Kyoto University)	Identification of a novel HIV-1 restriction factor which selectively degrades viral transcripts.

12. Bacterial / mycofungal / parasite infection

Program No	Name	Title
1-E-W10-12-O/P	Keigo Ueno (National Institute of Infectious Diseases)	Dendritic cell-based vaccination induces lung resident memory Th17 cells that ameliorate pulmonary infection with highly virulent Cryptococcus gattii
1-E-W9-2-O/P	Imai Takashi (Kyushu University)	Glycolipids in group A Streptococcus are recognized by Mincle to trigger host immune responses

13. Endogenous innate immunity and inflammation

Program No	Name	Title
1-B-W3-8-O/P	Masahiro Nagata (Osaka University)	Intracellular metabolite, β-glucosylceramide, is an endogenous adjuvant acting through Mincle
1-B-W4-8-O/P	Kafi N. Ealey (RIKEN IMS)	Mechanisms for the regulation of adipose tissue expansion and remodeling by group 2 innate lymphoid cells

14. Mucosal-Skin Immunity

Program No	Name	Title
2-A-W19-3-O/P	Daisuke Takahashi (Keio University Faculty of Pharmacy)	Microbial fermentation product butyrate Ameliorates Autoimmune Arthritis.
2-A-W19-8-O/P	Takahiro Nagatake (National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN))	17,18-EpETE, a metabolite of omega-3 essential fatty acids, inhibited neutrophil mobility and ameliorated skin inflammation in DNFB-induced contact hypersensitivity model

15. Tissue-specific immune diseases

Program No	Name	Title
3-H-W41-13-O/P	Yosuke Kurashima (The University of Tokyo)	Mesenchymal-myeloid cell interactions in renal microenvironment for pathological fibrogenic machinery in kidney fibrosis
1-C-W5-1-O/P	Ben Raveney (NCNP)	Eomes-positive cytotoxic T helper cells: a new pathogenic immune cell subset in secondary progressive multiple sclerosis?

16. Systemic autoimmune diseases

Program No	Name	Title
3-G-W38-1-O/P	Shigeru Iwata (University of Occupational & Environmental Health)	IFN-γ-T-bet mediated metabolic reprograming in T　helper 1 cellsand its relevance to pathogenesis of SLE
3-G-W38-3-O/P	Yusuke Takeshima (The University of Tokyo)	Comprehensive analysis of genome and transcriptome analysis of immune cell subsets in peripheral blood mononuclear cells (PBMCs) revealed mitochondria contribution in B cells to systemic lupus erythematosus.

17. Tumor immunity

Program No	Name	Title
3-D-W32-11-O/P	Hisashi Kanemaru (Osaka University)	Basic leucine zipper transcription factor ATF-like 2 exhibits an anti-tumor effect through upregulation of IL-12 p40 expression
3-D-W33-1-O/P	Okumura Genki (University of Tsukuba)	The role of soluble CD155 in tumor immune response and metastasis

18. Cancer immunotherapy

Program No	Name	Title
1-F-W11-11-O/P	Chang-Yu Chen (The University of Tokyo)	Low-dose HMGN1 synergistically enhances anti-tumor immunity in CD4 depleting antibody-treated mice
1-F-W12-10-O/P	Yoshino Tanaka (Hokkaido University)	Dying but not dead cancer cells exert the effect of cell-based cancer vaccine

19. Human Immunology (Immunointervention)

Program No	Name	Title
1-I-W17-1-O/P	Yuki Hitomi (The University of Tokyo)	Identification of the disease causal variants in human primary biliary cholangitis (PBC) susceptibility gene loci NFKB1/MANBA